| RS2131033078 |
LHX3
|
Health Risk |
Pathogenic |
— |
| RS2131034777 |
LHX3
|
Health Risk |
Likely pathogenic |
Non-acquired combined pituitary hormone deficiency with spine abnormalities, Non-acquired combined pituitary hormone deficiency with spine abnormalities |
| RS2131036410 |
LHX3
|
Health Risk |
Pathogenic |
Non-acquired combined pituitary hormone deficiency with spine abnormalities, Non-acquired combined pituitary hormone deficiency with spine abnormalities |
| RS2131048008 |
MTAP
|
Health Risk |
Pathogenic |
Diaphyseal medullary stenosis-bone malignancy syndrome, Diaphyseal medullary stenosis-bone malignancy syndrome |
| RS2131048129 |
MTAP
|
Health Risk |
Pathogenic |
Diaphyseal medullary stenosis-bone malignancy syndrome, Diaphyseal medullary stenosis-bone malignancy syndrome |
| RS2131051951 |
FANCG
|
Health Risk |
Pathogenic |
Fanconi anemia, Fanconi anemia complementation group G |
| RS2131051986 |
FANCG
|
Health Risk |
Likely pathogenic |
Fanconi anemia, Fanconi anemia |
| RS2131051989 |
FANCG
|
Health Risk |
Likely pathogenic |
Fanconi anemia, Fanconi anemia |
| RS2131053086 |
FANCG
|
Health Risk |
Pathogenic |
Fanconi anemia, Fanconi anemia |
| RS2131053141 |
FANCG
|
Health Risk |
Likely pathogenic |
Fanconi anemia, Fanconi anemia |
| RS2131053417 |
FANCG
|
Health Risk |
Pathogenic |
Fanconi anemia, Fanconi anemia |
| RS2131053755 |
FANCG
|
Health Risk |
Conflicting classifications of pathogenicity |
Fanconi anemia, Fanconi anemia complementation group G |
| RS2131053777 |
FANCG
|
Health Risk |
Pathogenic |
— |
| RS2131053808 |
FANCG
|
Health Risk |
Likely pathogenic |
Fanconi anemia, Fanconi anemia |
| RS2131053817 |
FANCG
|
Health Risk |
Likely pathogenic |
Fanconi anemia, Fanconi anemia |
| RS2131053943 |
FANCG
|
Health Risk |
Pathogenic |
Fanconi anemia, Fanconi anemia complementation group G |
| RS2131054083 |
FANCG
|
Health Risk |
Pathogenic |
Fanconi anemia, Fanconi anemia |
| RS2131055360 |
FANCG
|
Health Risk |
Pathogenic |
Fanconi anemia, Fanconi anemia |
| RS2131055405 |
FANCG
|
Health Risk |
Pathogenic |
Fanconi anemia, Fanconi anemia |
| RS2131055463 |
FANCG
|
Health Risk |
Pathogenic/Likely pathogenic |
Fanconi anemia, Fanconi anemia complementation group G |
| RS2131055534 |
FANCG
|
Health Risk |
Likely pathogenic |
Fanconi anemia complementation group G, Fanconi anemia complementation group G |
| RS2131055853 |
FANCG
|
Health Risk |
Pathogenic/Likely pathogenic |
FANCG-related disorder, Fanconi anemia |
| RS2131055994 |
FANCG
|
Health Risk |
Likely pathogenic |
Fanconi anemia complementation group G, Fanconi anemia complementation group G |
| RS2131056131 |
FANCG
|
Health Risk |
Likely pathogenic |
Carcinoma of pancreas, Carcinoma of pancreas |
| RS2131056296 |
TAF2
|
Health Risk |
Likely pathogenic |
— |
| RS2131056491 |
FANCG
|
Health Risk |
Likely pathogenic |
Fanconi anemia complementation group G, Fanconi anemia complementation group G |
| RS2131056549 |
FANCG
|
Health Risk |
Pathogenic/Likely pathogenic |
Fanconi anemia, Fanconi anemia complementation group G |
| RS2131056614 |
FANCG
|
Health Risk |
Pathogenic |
Fanconi anemia, Fanconi anemia |
| RS2131056701 |
FANCG
|
Health Risk |
Likely pathogenic |
Fanconi anemia, Abnormality of blood and blood-forming tissues |
| RS2131057155 |
FANCG
|
Health Risk |
Likely pathogenic |
Fanconi anemia complementation group G, Fanconi anemia complementation group G |
| RS2131057213 |
FANCG
|
Health Risk |
Pathogenic |
Fanconi anemia, Fanconi anemia |
| RS2131058481 |
FANCG
|
Health Risk |
Pathogenic |
Fanconi anemia, Fanconi anemia |
| RS2131058553 |
FANCG
|
Health Risk |
Pathogenic |
Fanconi anemia, Fanconi anemia |
| RS2131058595 |
FANCG
|
Health Risk |
Pathogenic |
Fanconi anemia, Fanconi anemia complementation group G |
| RS2131059176 |
FANCG
|
Health Risk |
Likely pathogenic |
Fanconi anemia, Fanconi anemia |
| RS2131059848 |
FANCG
|
Health Risk |
Pathogenic/Likely pathogenic |
Fanconi anemia, Fanconi anemia complementation group G |
| RS2131060266 |
FANCG
|
Health Risk |
Pathogenic |
Fanconi anemia, Fanconi anemia |
| RS2131061695 |
SPTAN1
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Early-infantile DEE |
| RS2131063622 |
TAF2
|
Health Risk |
Pathogenic/Likely pathogenic |
Microcephaly-thin corpus callosum-intellectual disability syndrome, Microcephaly-thin corpus callosum-intellectual disability syndrome |
| RS2131073372 |
PIGO
|
Health Risk |
Pathogenic |
Hyperphosphatasia with intellectual disability syndrome 2, Hyperphosphatasia with intellectual disability syndrome 2 |
| RS2131074060 |
PIGO
|
Health Risk |
Pathogenic |
Hyperphosphatasia with intellectual disability syndrome 2, Hyperphosphatasia with intellectual disability syndrome 2 |
| RS2131074579 |
PIGO
|
Health Risk |
Pathogenic |
Hyperphosphatasia with intellectual disability syndrome 2, Hyperphosphatasia with intellectual disability syndrome 2 |
| RS2131075608 |
PIGO
|
Health Risk |
Pathogenic |
Hyperphosphatasia with intellectual disability syndrome 2, Hyperphosphatasia with intellectual disability syndrome 2 |
| RS2131076903 |
MED27
|
Health Risk |
Pathogenic |
Neurodevelopmental disorder with spasticity, cataracts |
| RS2131077198 |
PIGO
|
Health Risk |
Pathogenic |
Hyperphosphatasia with intellectual disability syndrome 2, Hyperphosphatasia with intellectual disability syndrome 2 |
| RS2131081539 |
PLEC
|
Health Risk |
Pathogenic |
Epidermolysis bullosa simplex 5C, with pyloric atresia |
| RS2131083888 |
PIGO
|
Health Risk |
Pathogenic |
Hyperphosphatasia with intellectual disability syndrome 2, Hyperphosphatasia with intellectual disability syndrome 2 |
| RS2131087593 |
KRIT1
|
Health Risk |
Likely pathogenic |
Cerebral cavernous malformation, Cerebral cavernous malformation |
| RS2131087886 |
KRIT1
|
Health Risk |
Pathogenic |
Cerebral cavernous malformation, Cerebral cavernous malformation |
| RS2131088062 |
KRIT1
|
Health Risk |
Pathogenic |
Cerebral cavernous malformation, Cerebral cavernous malformation |
| RS2131088567 |
SPTAN1
|
Health Risk |
Pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS2131088953 |
KRIT1
|
Health Risk |
Pathogenic |
Cerebral cavernous malformation, Cerebral cavernous malformation |
| RS2131089190 |
KRIT1
|
Health Risk |
Pathogenic |
Cerebral cavernous malformation, Cerebral cavernous malformation |
| RS2131089744 |
KRIT1
|
Health Risk |
Pathogenic |
Cerebral cavernous malformation, Cerebral cavernous malformation |
| RS2131094090 |
CDKN2A
|
Health Risk |
Pathogenic/Likely pathogenic |
Familial melanoma, Familial melanoma |
| RS2131094356 |
CDKN2A
|
Health Risk |
Pathogenic/Likely pathogenic |
Melanoma-pancreatic cancer syndrome, Familial melanoma |
| RS2131094486 |
CDKN2A
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial melanoma, Hereditary cancer-predisposing syndrome |
| RS2131095688 |
CDKN2A
|
Health Risk |
Likely pathogenic |
Hereditary cancer-predisposing syndrome, Melanoma-pancreatic cancer syndrome |
| RS2131095862 |
CDKN2A
|
Health Risk |
Pathogenic |
Familial melanoma, Familial melanoma |
| RS2131096063 |
CDKN2A
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial melanoma, Hereditary cancer-predisposing syndrome |
| RS2131096164 |
CDKN2A
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial melanoma, Hereditary cancer-predisposing syndrome |
| RS2131096613 |
CDKN2A
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial melanoma, Hereditary cancer-predisposing syndrome |
| RS2131096682 |
CDKN2A
|
Health Risk |
Likely pathogenic |
Familial melanoma, Familial melanoma |
| RS2131096806 |
CDKN2A
|
Health Risk |
Likely pathogenic |
— |
| RS2131101239 |
ADAMTSL2
|
Health Risk |
Likely pathogenic |
— |
| RS2131107 |
DAG1
|
Health Risk |
Pathogenic |
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A9 |
| RS2131108640 |
DCLRE1C
|
Health Risk |
Likely pathogenic |
Severe combined immunodeficiency due to DCLRE1C deficiency, Severe combined immunodeficiency due to DCLRE1C deficiency |
| RS2131111833 |
CDKN2A
|
Health Risk |
Likely pathogenic |
Melanoma-pancreatic cancer syndrome, Familial melanoma |
| RS2131112280 |
CDKN2A
|
Health Risk |
Pathogenic |
Familial melanoma, Melanoma-pancreatic cancer syndrome |
| RS2131113797 |
CDKN2A
|
Health Risk |
Pathogenic |
Familial melanoma, Familial melanoma |
| RS2131113914 |
CDKN2A
|
Health Risk |
Pathogenic |
Familial melanoma, Familial melanoma |
| RS2131114005 |
CDKN2A
|
Health Risk |
Pathogenic |
Melanoma-pancreatic cancer syndrome, Melanoma-pancreatic cancer syndrome |
| RS2131115543 |
SETX
|
Health Risk |
Pathogenic |
Spinocerebellar ataxia, autosomal recessive |
| RS2131116061 |
RFX3
|
Health Risk |
Likely pathogenic |
Neurodevelopmental disorder, Neurodevelopmental disorder |
| RS2131116547 |
ASPH
|
Health Risk |
Likely pathogenic |
Facial dysmorphism-lens dislocation-anterior segment abnormalities-spontaneous filtering blebs syndrome, Facial dysmorphism-lens dislocation-anterior segment abnormalities-spontaneous filtering blebs syndrome |
| RS2131116634 |
TRAPPC9
|
Health Risk |
Pathogenic |
— |
| RS2131117340 |
TRAPPC9
|
Health Risk |
Likely pathogenic |
Abnormality of the nervous system, Abnormality of the nervous system |
| RS2131119729 |
TEK
|
Health Risk |
Likely pathogenic |
Glaucoma 3, primary congenital |
| RS2131122992 |
VPS13A
|
Health Risk |
Pathogenic |
— |
| RS2131123226 |
VPS13A
|
Health Risk |
Pathogenic |
— |
| RS2131123295 |
VPS13A
|
Health Risk |
Likely pathogenic |
— |
| RS2131125631 |
VPS13A
|
Health Risk |
Pathogenic |
— |
| RS2131127437 |
DOLK
|
Health Risk |
Likely pathogenic |
— |
| RS2131131580 |
MAN1B1
|
Health Risk |
Likely pathogenic |
See cases, See cases |
| RS2131137637 |
SETX
|
Health Risk |
Likely pathogenic |
— |
| RS2131140222 |
VPS13A
|
Health Risk |
Likely pathogenic |
Chorea-acanthocytosis, Chorea-acanthocytosis |
| RS2131141182 |
TEK
|
Health Risk |
Likely pathogenic |
Glaucoma 3, primary congenital |
| RS2131147945 |
CDKN2A
|
Health Risk |
Likely pathogenic |
Familial melanoma, Hereditary cancer-predisposing syndrome |
| RS2131147969 |
CDKN2A
|
Health Risk |
Pathogenic/Likely pathogenic |
Familial melanoma, Hereditary cancer-predisposing syndrome |
| RS2131148082 |
CDKN2A
|
Health Risk |
Likely pathogenic |
Familial melanoma, Familial melanoma |
| RS2131148265 |
CDKN2A
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial melanoma, Melanoma and neural system tumor syndrome |
| RS2131148302 |
CDKN2A
|
Health Risk |
Pathogenic |
Familial melanoma, Familial melanoma |
| RS2131148531 |
CDKN2A
|
Health Risk |
Likely pathogenic |
Familial melanoma, Familial melanoma |
| RS2131148812 |
CDKN2A
|
Health Risk |
Likely pathogenic |
Familial melanoma, Familial melanoma |
| RS2131150312 |
DNM1
|
Health Risk |
Conflicting classifications of pathogenicity |
Developmental and epileptic encephalopathy, 31A |
| RS2131151265 |
ELN
|
Health Risk |
Pathogenic |
Supravalvar aortic stenosis, Supravalvar aortic stenosis |
| RS2131152462 |
VPS13A
|
Health Risk |
Likely pathogenic |
— |
| RS2131152526 |
ELN
|
Health Risk |
Likely pathogenic |
— |
| RS2131153571 |
VPS13A
|
Health Risk |
Pathogenic |
— |
| RS2131153683 |
VPS13A
|
Health Risk |
Pathogenic |
Chorea-acanthocytosis, Chorea-acanthocytosis |